कृपया अन्य खोज का प्रयास करें
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed or refractory for non-hodgkin lymphoma (NHL); and ALLO-715 for the treatment of multiple myeloma. It also develops UCART22 to treat B-cell acute lymphoblastic leukemia; UCARTCS1 and ALLO-605 for the treatment of multiple myeloma; ALLO-316 for renal cell carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART 20x22 for relapsed or refractory B-Cell NHL. The company has strategic alliances with Allogene Therapeutics, Inc. and Les Laboratoires Servier; research collaboration and exclusive license agreement with Iovance Biotherapeutics; and collaboration and license agreement with Cytovia, as well as a collaboration agreement with AstraZeneca to develop novel cell and gene therapy candidate products. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Andre Choulika | 58 | 1999 | Co-Founder, CEO & Director |
Jean-Pierre Garnier | 76 | 2020 | Independent Non-Executive Chairman |
Marcela V. Maus | 46 | 2017 | Member of Clinical Advisory Board |
Ghulam J. Mufti | - | - | Member of Clinical Advisory Board |
Dietger Niederwieser | - | 2017 | Member of Clinical Advisory Board |
Ola Landgren | - | 2017 | Member of Clinical Advisory Board |
Kanti Rai | - | 2017 | Member of Clinical Advisory Board |
Catherine Bollard | 54 | 2017 | Member of Clinical Advisory Board |
Stephan A. Grupp | - | 2018 | Member of Clinical Advisory Board |
Cecile Chartier | - | 2023 | Director |
David J. D. Sourdive | 56 | 2000 | Deputy CEO, Executive VP of CMC & Manufacturing and Director |
Rainer J. Boehm | 63 | 2017 | Director |
Pierre Bastid | 69 | 2011 | Director |
Donald A. Bergstrom | 51 | 2021 | Director |
Axel-Sven Malkomes | 56 | 2022 | Director |
Laurent Arthaud | 60 | 2011 | Director |
Marc Dunoyer | 72 | 2023 | Director |
Tyrell Rivers | 51 | 2023 | Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है